BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25156819)

  • 1. Protein expression and promoter methylation of the candidate biomarker TCF21 in gastric cancer.
    Yang Z; Li DM; Xie Q; Dai DQ
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):211-20. PubMed ID: 25156819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma.
    Ye YW; Jiang ZM; Li WH; Li ZS; Han YH; Sun L; Wang Y; Xie J; Liu YC; Zhao J; Tang AF; Li XX; Guan ZC; Gui YT; Cai ZM
    Neoplasma; 2012; 59(6):599-605. PubMed ID: 22862160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma.
    Arab K; Smith LT; Gast A; Weichenhan D; Huang JP; Claus R; Hielscher T; Espinosa AV; Ringel MD; Morrison CD; Schadendorf D; Kumar R; Plass C
    Carcinogenesis; 2011 Oct; 32(10):1467-73. PubMed ID: 21771727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
    He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
    Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.
    Kanda M; Shimizu D; Nomoto S; Takami H; Hibino S; Oya H; Hashimoto R; Suenaga M; Inokawa Y; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Gastric Cancer; 2015 Apr; 18(2):288-96. PubMed ID: 24695972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of aberrant hypermethylated spastic paraplegia-20 as a potential biomarker and prognostic factor in gastric cancer.
    Zhang H; Song Y; Xia P; Cheng Y; Guo Q; Diao D; Wang W; Wu X; Liu D; Dang C
    Med Oncol; 2014 Feb; 31(2):830. PubMed ID: 24381142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer.
    Hu C; Lin F; Zhu G; Xue X; Ding Y; Zhao Z; Zhang L; Shen X
    Int J Oncol; 2013 Nov; 43(5):1487-94. PubMed ID: 23982764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.
    Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ
    Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
    Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C
    Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma.
    Chen Y; Zhang C; Chen J; Zhang B; Zhang H; Yang X; Liu J; Wu Q
    Med Sci Monit; 2018 Jun; 24():4128-4136. PubMed ID: 29909422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers.
    Richards KL; Zhang B; Sun M; Dong W; Churchill J; Bachinski LL; Wilson CD; Baggerly KA; Yin G; Hayes DN; Wistuba II; Krahe R
    Cancer; 2011 Feb; 117(3):606-17. PubMed ID: 20945327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma.
    Weiss D; Stockmann C; Schrödter K; Rudack C
    Cell Oncol (Dordr); 2013 Jun; 36(3):213-24. PubMed ID: 23529585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
    Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
    Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lin28 promotes Her2 expression and Lin28/Her2 predicts poorer survival in gastric cancer.
    Wang Q; Zhou J; Guo J; Teng R; Shen J; Huang Y; Xie S; Wei Q; Zhao W; Chen W; Yuan X; Chen Y; Wang L
    Tumour Biol; 2014 Nov; 35(11):11513-21. PubMed ID: 25128063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression tendency and prognostic value of TCF21 in hepatocellular carcinoma.
    Lu W; Yang C; Du P; Zhang JL; Zhang JC
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1466-1470. PubMed ID: 31014118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.
    Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D
    Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer.
    Otani K; Dong Y; Li X; Lu J; Zhang N; Xu L; Go MY; Ng EK; Arakawa T; Chan FK; Sung JJ; Yu J
    J Pathol; 2014 Nov; 234(3):302-15. PubMed ID: 24931004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
    Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a LINE-1 endonuclease variant in gastric cancer: its association with clinicopathological parameters.
    Wang G; Gao J; Huang H; Tian Y; Xue L; Wang W; You W; Lian H; Duan X; Wu B; Wang M
    BMC Cancer; 2013 May; 13():265. PubMed ID: 23718141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.